Truhome Finance IPO Review

Status (upcoming): Truhome Finance filed its DRHP with SEBI on 9 March 2026. The IPO date, price band, lot size and GMP are all still unannounced — the company is expected to open the issue in the coming months once SEBI clears it. The total size is ₹3,000 crore (₹1,500 crore fresh issue + ₹1,500 crore offer-for-sale), listing on NSE and BSE. This is one to watch, not act on yet.

About the Company

Buying a first home in a small town is hard when your income comes from running a shop or a small business, not a salaried job with neat payslips. Big banks often say no to those files. Truhome Finance was built to say yes.

Founded in 2010, Truhome is an affordable housing finance company until recently you knew it as Shriram Housing Finance. Global private-equity firm Warburg Pincus bought it in December 2024 and rebranded it to Truhome. It lends mostly to self-employed customers, financing the purchase, construction or renovation of homes.

Its main products are home loans, about 57% of the book, and loans against property. The average loan is around ₹21 lakh small-ticket, retail, spread thin. As of December 2025 it managed ₹21,124 crore in assets across 216 branches in 19 states, making it the third-largest affordable housing financier in India. Chairman Dinesh Kumar Khara, the former SBI chief, leads the board. Track its IPO updates on the IPO GMP Live homepage.

Financial Snapshot

The growth here is the headline. Total income climbed from ₹781 crore in FY23 to ₹1,425 crore in FY24 to ₹1,905 crore in FY25. Profit kept pace ₹138 crore, ₹217 crore, then ₹286 crore across those years. For the nine months of FY26 it had already made ₹334 crore, more than its entire FY25 profit, so the momentum is real.

Under the bonnet, Truhome is the fastest-growing affordable housing financier in India, compounding assets at about 49% a year over FY23–FY25. Asset quality looks clean too net Stage-3 (bad loans) sat at just 1.09%, low for a lender growing this fast.

What I'd watch is exactly that speed. A loan book growing at nearly 50% a year hasn't fully seasoned you only learn how good the lending was when those loans are a few years old and the economy turns. Fast growth in lending can hide problems that surface later.

The other thing is the IPO structure. Half the ₹3,000 crore is an offer-for-sale by Warburg Pincus, which only bought the company in December 2024. The owner taking ₹1,500 crore off the table barely two years in is worth noting, even if it's normal for a PE-backed listing.

Strengths

• It's the fastest-growing affordable HFC in India. Assets compounded at about 49% a year over FY23–FY25 to reach ₹21,124 crore, making it the third-largest in the segment. The nine-month FY26 profit of ₹334 crore already tops the full FY25 figure, so the momentum is carrying on.
• The backing is heavyweight. Warburg Pincus owns the company, and the board is chaired by Dinesh Kumar Khara, the former chairman of SBI. That combination brings deep capital, governance credibility and lending expertise that smaller rivals can't match.
• Asset quality is clean. Net Stage-3 bad loans were just 1.09%, and the company is among the most cost-efficient in its peer group on operating expenses. Growing fast while keeping NPAs low is the hard part, and it's managing it so far.
• The book is well spread. With 216 branches across 19 states and no single state making up more than 18% of loans, Truhome isn't over-reliant on any one region a real plus for a lender to the self-employed.

Risks

• There's no price band yet. Until the valuation is announced, you simply can't judge whether the IPO is good value. A fast-growing lender can still be a poor investment at the wrong price, and the price is the whole question here.
• Half the issue is an exit. ₹1,500 crore of the ₹3,000 crore is Warburg Pincus selling, only about two years after buying the company. Just ₹1,500 crore of fresh capital actually goes into the business to fund lending.
• Rapid growth carries seasoning risk. A loan book expanding near 50% a year hasn't been tested through a full cycle. If the economy slows, bad loans from this fast-growth phase could show up later, which is the classic NBFC trap.
• It's a crowded, rate-sensitive space. Affordable housing finance has many strong players Aavas, Home First, Aptus, India Shelter and others and as an NBFC, Truhome's margins move with funding costs and RBI policy. For reference on how the market treats a recent housing financier, see our Bajaj Housing Finance IPO review.

Should You Apply?

There's no decision to make yet the IPO date, price band and lot size are all still unannounced. The DRHP was filed in March 2026 and the issue is expected to open in the coming months. So this is one to watch, not act on.

When the price band does arrive, here's how I'd think about it.

Conservative investors — wait for the valuation and at least one round of listed-peer comparison. A fast-growing lender can be a fine business at the wrong price.

Moderate investors — the fundamentals are strong, so a reasonable price band makes this worth a look for one lot.

Aggressive investors — the growth and the Warburg Khara backing will draw attention; watch the GMP and subscription once it goes live.

Honest take: a genuinely strong affordable-housing lender but until the price is out, there's nothing to apply for.

IPO Objects of the Issue

The issue is an equal split a ₹1,500 crore fresh issue and a ₹1,500 crore offer for sale. The OFS proceeds go to the selling promoter, not the company. Exact use of the fresh proceeds will be confirmed in the final RHP.

Contact Details

Truhome Finance Ltd. (formerly Shriram Housing Finance Ltd.) Level 3, Wockhardt Towers, East Wing, C-2, G Block, Bandra-Kurla Complex, Mumbai – 400051, Maharashtra 📞 +91 22 4241 0400 🌐 www.truhomefinance.in

IPO Registrar — KFin Technologies Ltd. 📞 040-6716 2222 / 040-7961 1000 📧 einward.ris@kfintech.com 🌐 www.kfintech.com

Lead Manager: JM Financial Ltd.

Related IPO reviews: Bajaj Housing Finance IPO · HDB Financial Services IPO · Tata Capital IPO · Hyundai Motor India IPO · Meesho IPO · Lenskart IPO · Zepto IPO · Vahh Chemicals IPO

This page is not investment advice. GMP is indicative only. Please consult a SEBI-registered financial advisor before investing.